Cannara Biotech Inc. (TSXV: LOVE) (OTCQB: LOVFF) announced a solid fiscal first quarter of 2025 for the quarter ending November 30, 2024. The Canadian company reported that its cannabis revenues increased by 33% to C$34.9 million in the quarter, up from last year’s C$26.3 million. The company attributed the increase to…
Please login to read all 545 words.
